Toshihiko Akimoto

676 total citations
18 papers, 565 citations indexed

About

Toshihiko Akimoto is a scholar working on Immunology, Cancer Research and Molecular Biology. According to data from OpenAlex, Toshihiko Akimoto has authored 18 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Toshihiko Akimoto's work include Cytokine Signaling Pathways and Interactions (4 papers), Liver physiology and pathology (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Toshihiko Akimoto is often cited by papers focused on Cytokine Signaling Pathways and Interactions (4 papers), Liver physiology and pathology (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Toshihiko Akimoto collaborates with scholars based in Japan and Germany. Toshihiko Akimoto's co-authors include Fumio Numata, Tohru Takashi, Yoshimi Takata, M. Tamura, Kiyoshi Takeda, Shizuo Akira, Yuichi Sekine, Tadashi Matsuda, Kazuya Shimoda and Ryuta Muromoto and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Scientific Reports.

In The Last Decade

Toshihiko Akimoto

18 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toshihiko Akimoto Japan 10 338 202 185 89 66 18 565
Søren Ulrik Sønder United States 11 268 0.8× 77 0.4× 74 0.4× 100 1.1× 56 0.8× 15 484
Kazuhiko Yamamoto Japan 8 227 0.7× 81 0.4× 108 0.6× 90 1.0× 22 0.3× 8 471
Andreas Kislat Germany 8 162 0.5× 137 0.7× 117 0.6× 101 1.1× 36 0.5× 14 481
Patty Trobridge United States 11 134 0.4× 190 0.9× 65 0.4× 262 2.9× 34 0.5× 12 571
Andrew M. Guzman United States 7 828 2.4× 183 0.9× 246 1.3× 187 2.1× 26 0.4× 7 1.1k
David Bastian United States 20 591 1.7× 164 0.8× 30 0.2× 295 3.3× 52 0.8× 42 1.0k
S Furuta Japan 15 80 0.2× 146 0.7× 53 0.3× 182 2.0× 93 1.4× 45 746
Ray A. Johnson United States 7 525 1.6× 83 0.4× 84 0.5× 82 0.9× 9 0.1× 8 666
Azumi Ueyama Japan 10 193 0.6× 115 0.6× 83 0.4× 62 0.7× 33 0.5× 18 589
Erin E. Childs United States 10 246 0.7× 192 1.0× 48 0.3× 243 2.7× 30 0.5× 12 648

Countries citing papers authored by Toshihiko Akimoto

Since Specialization
Citations

This map shows the geographic impact of Toshihiko Akimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshihiko Akimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshihiko Akimoto more than expected).

Fields of papers citing papers by Toshihiko Akimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshihiko Akimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshihiko Akimoto. The network helps show where Toshihiko Akimoto may publish in the future.

Co-authorship network of co-authors of Toshihiko Akimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Toshihiko Akimoto. A scholar is included among the top collaborators of Toshihiko Akimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshihiko Akimoto. Toshihiko Akimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kaji, Tomohiro, et al.. (2020). Characterization of cereblon-dependent targeted protein degrader by visualizing the spatiotemporal ternary complex formation in cells. Scientific Reports. 10(1). 3088–3088. 9 indexed citations
2.
3.
Ishizaki, Masayuki, Ryuta Muromoto, Toshihiko Akimoto, et al.. (2013). Tyk2 is a therapeutic target for psoriasis-like skin inflammation. International Immunology. 26(5). 257–267. 64 indexed citations
4.
Ishizaki, Masayuki, Toshihiko Akimoto, Ryuta Muromoto, et al.. (2011). Involvement of Tyrosine Kinase-2 in Both the IL-12/Th1 and IL-23/Th17 Axes In Vivo. The Journal of Immunology. 187(1). 181–189. 88 indexed citations
5.
Shimizu, H., Shinji Tanaka, Isao Yasumatsu, et al.. (2010). Discovery of imidazo[1,2-b]pyridazine derivatives as IKKβ inhibitors. Part 1: Hit-to-lead study and structure–activity relationship. Bioorganic & Medicinal Chemistry Letters. 20(17). 5113–5118. 16 indexed citations
6.
Yamamoto, Tetsuya, Seiyu Imoto, Yuichi Sekine, et al.. (2003). Involvement of NF- B in TGF- -mediated suppression of IL-4 signaling. Biochemical and Biophysical Research Communications. 313(3). 627–634. 12 indexed citations
7.
Akimoto, Toshihiko, Fumio Numata, M. Tamura, et al.. (1998). Abrogation of Bronchial Eosinophilic Inflammation and Airway Hyperreactivity in Signal Transducers and Activators of Transcription (STAT)6-deficient Mice. The Journal of Experimental Medicine. 187(9). 1537–1542. 262 indexed citations
8.
9.
10.
Jimbo, Takeshi, Toshihiko Akimoto, & Akiko Tohgo. (1995). Effect of combined administration of a synthetic low-toxicity lipid A derivative, DT-5461a, and indomethacin in various experimental tumor models of colon 26 carcinoma in mice. Cancer Immunology Immunotherapy. 40(1). 10–16. 11 indexed citations
11.
12.
Jimbo, Takahiro, Toshihiko Akimoto, & Akiko Tohgo. (1995). Effect of combined administration of a synthetic low-toxicity lipid A derivative, DT-5461a, and indomethacin in various experimental tumor models of colon 26 carcinoma in mice. Cancer Immunology Immunotherapy. 40(1). 10–16. 2 indexed citations
13.
Akahane, Kouichi, Kazuhiko Someya, Yumi Tsutomi, Toshihiko Akimoto, & Akiko Tohgo. (1994). Antitumor Synthetic Lipid A Analog DT-5461a Upregulates Cytokine Expression in a Murine Macrophage Cell Line through LPS Pathway. Cellular Immunology. 155(1). 42–52. 9 indexed citations
14.
Akimoto, Toshihiko, et al.. (1994). Antitumor effect of DT-5461a, a synthetic low-toxicity lipid a analog, involves endogenous tumor necrosis factor induction subsequent to macrophage activation. International Journal of Immunopharmacology. 16(11). 887–893. 12 indexed citations
15.
Miura, Yoshiharu, Toshihiko Akimoto, Noriko Yoshikawa, & Kiyohito Yagi. (1990). Characterization of Immobilized Hepatocytes as Liver Support. Biomaterials Artificial Cells and Artificial Organs. 18(4). 549–554. 6 indexed citations
16.
Akimoto, Toshihiko, Kiyohito Yagi, & Yoshiharu Miura. (1987). Ability of gluconeogenesis and its hormonal regulation in cultured hepatocytes entrapped within Ca-alginate.. 16(2). 920–923. 3 indexed citations
17.
Miura, Yoshiharu, et al.. (1987). In Vitro Maintenance of Terminal‐Differentiated State in Hepatocytes Entrapped Within Calcium Alginate. Artificial Organs. 11(5). 361–365. 17 indexed citations
18.
Akimoto, Toshihiko, et al.. (1985). FUNDAMENTAL STUDIES ON BIOLOGICAL ARTIFICIAL LIVER SUPPORT; LIVER FUNCTIONS OF ENTRAPPED HEPATOCYTES. 14(1). 249–252. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Søren Ulrik Sønder Breakdown of academic impact, for papers by Kazuhiko Yamamoto Breakdown of academic impact, for papers by Andreas Kislat Breakdown of academic impact, for papers by Patty Trobridge Breakdown of academic impact, for papers by Andrew M. Guzman Breakdown of academic impact, for papers by David Bastian Breakdown of academic impact, for papers by S Furuta Breakdown of academic impact, for papers by Ray A. Johnson Breakdown of academic impact, for papers by Azumi Ueyama Breakdown of academic impact, for papers by Erin E. Childs
Rankless by CCL
2026